MedPath

Development and Validation of a Short Tool to Assess the Awareness of Pregnancy-induced Hypertension

Completed
Conditions
Hypertension in Pregnancy
Pregnancy Related
Registration Number
NCT05859282
Lead Sponsor
Georges Hatem
Brief Summary

Background: Pregnancy-induced hypertension (PIH) is responsible for most perinatal and fetal mortality. Few programs are patient-centered during pregnancy, increasing the risks of misinformation and misconceptions among pregnant women and, as a result, malpractices. Objective: This study aims to develop and validate a form to assess the knowledge and attitudes of pregnant women about PIH.

Detailed Description

Many observational studies explored the awareness of pregnant women of PIH, but no structured tool is available to assess such awareness. During the past two years, education campaigns were postponed and primary care was prioritized. To allow better-informed decisions and targeted actions, this pilot study aims to develop and validate a short form to assess the knowledge and attitudes of pregnant women about pregnancy-induced hypertension. The long-term objective of this study is to provide a practical tool for pregnant women.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
135
Inclusion Criteria
  • Participants were asked to participate in the study with no criteria based on race, ethnicity, or gestational age.
Exclusion Criteria
  • Those with a history of hypertension or pre-eclampsia were excluded.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Awareness of hypertensive disorders of pregnancy by developing a 25-item questionnaire6 months

Thirty-six statements were initially provided to which women had to answer either ''yes'', ''No'' or ''I don't Know''. Out of these statements, 25 were retained due to positive inter-item correlation (15 knowledge statements and 10 behavior statements), and the other statements were eliminated one by one after testing for reliability and computing the effect of each statement on the internal consistency.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Lebanese University Faculty of pharmacy

🇱🇧

Beirut, Lebanon

© Copyright 2025. All Rights Reserved by MedPath